Q&A session with Drs. @LudaBazhenovaMD, Christina Baik, and @TejasPatilMD.

"How do you describe the 'quality of life' metric for targeted therapy?"

#LungCancer #EGFR #TP53 #RB1 #BRAF #NSCLC #SCLC #TargetedTherapies #LungCancerInformation

Do you want to learn more about #BRAF?

Join us now at our Lung Cancer Targeted Therapies OncTalk!

#LungCancer #TargetedTherapies #V600E #NSCLC #GRACE #LungCancerInformation

We are back!

Now presenting: @TejasPatilMD. "We have come a long way. What the Lung Cancer Community Needs to Know about EGFR and HER2 Mutations."

Join us now!
https://give.cancergrace.org/event/lung-cancer-targeted-therapies-onctalk-2026/e759491

#LungCancer #TargetedTherapies #LungCancerInformation #GRACE

Dr. @SamtaniSuraj presenting: Cancer Cachexia, Key Takeaways.

- Cachexia is common, progressive, and clinically relevant.
- Early recognition is essential.
- The precachexia stage is the window of opportunity.
- Optimal strategies for treating cancer cachexia: major unmet need in oncology care.

#LungCancer #TargetedTherapiesOncTalk #LungCancerInformation #cachexia